Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases-Reference-Cited by-同舟云学术

Certolizumab Pegol: A Review in Inflammatory Autoimmune Diseases

Published:2016-10-04 Issue:6 Volume:30 Page:607-617
ISSN:1173-8804
Container-title:BioDrugs
language:en
Short-container-title:BioDrugs

Author:

Deeks Emma D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine,Biotechnology

Link

http://link.springer.com/content/pdf/10.1007/s40259-016-0197-y.pdf

Reference70 articles.

1. Disabled World. Autoimmune diseases: types, facts & information. 2016. http://www.disabled-world.com/health/autoimmunediseases/ . Accessed 5 July 2016.

2. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Understanding autoimmune diseases. 2016. http://www.niams.nih.gov/health_info/autoimmune . Accessed 5 July 2016.

3. Australasian Society of Clinical Immunology and Allergy. Autoimmune diseases. 2016. http://www.allergy.org.au . Accessed 5 July 2016.

4. UCB. Cimzia® (certolizumab pegol): US prescribing Information. 2016. http://www.fda.gov . Accessed 26 Sep 2016.

5. UCB Pharma S.A. Cimzia solution for injection: summary of product characteristics. 2016. http://www.ema.europa.eu . Accessed 26 Sep 2016.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Towards a structural and functional analysis of the immunoglobulin-fold proteome;Advances in Protein Chemistry and Structural Biology;2024

2. The role of inflammation in autoimmune disease: a therapeutic target;Frontiers in Immunology;2023-10-04

3. A CASE REPORT: CERTOLIZUMAB-INDUCED KOUNIS SYNDROME;Rheumatology Quarterly;2023-06-20

4. Anti-Drug Antibodies in the Biological Therapy of Autoimmune Rheumatic Diseases;Journal of Clinical Medicine;2023-05-04

5. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments;Journal of Nanobiotechnology;2023-03-25